No pharma company has come close to adopting patient centricity. ZS principal Hensley Evans explains why, and shares what it will look like for companies when they finally transition to a patient-centric approach.
No pharma company has come close to adopting patient centricity. ZS principal Hensley Evans explains why, and shares what it will look like for companies when they finally transition to a patient-centric approach.